NASP Tells Congress and the Incoming Trump Administration: Pharmacies and Patients Can’t Continue to Wait for PBM Reform-Related Pharmacy Protections Read more
CALQUENCE ® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial Read more
Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis Read more
New report: For-profit clinics expanded by Ford government charging patients thousands in unlawful fees Read more
Some cancer patients can find it hard to tell family and friends about their diagnosis: ‘You’re dealing with this all alone’ Read more
Bringing confident diagnosis to more patients at low cost: Philips launches new AI-enabled CT 5300 at #ECR2024 Read more
Exclusive-Eisai expects 1,500 Alzheimer’s patients in China launch, sees ‘huge’ growth By Reuters Read more